These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18382927)

  • 1. Preparation and evaluation of stealth Tashinone IIA-loaded solid lipid nanoparticles: Influence of Poloxamer 188 coating on phagocytic uptake.
    Zhang W; Liu J; Li S; Chen M; Liu H
    J Microencapsul; 2008 May; 25(3):203-9. PubMed ID: 18382927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
    Zhang WL; Liu JP; Liu XX; Chen ZQ
    Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and pharmacokinetic evaluation of Tashinone IIA solid lipid nanoparticles.
    Liu J; Zhu J; Du Z; Qin B
    Drug Dev Ind Pharm; 2005 Jul; 31(6):551-6. PubMed ID: 16109628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In situ evading of phagocytic uptake of stealth solid lipid nanoparticles by mouse peritoneal macrophages.
    Wang Y; Wu W
    Drug Deliv; 2006; 13(3):189-92. PubMed ID: 16556570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of paclitaxel delivery system based on semi-solid lipid nanoparticles coated with poly (ethylene glycol).
    Wu L; Tang C; Yin C
    Pharmazie; 2010 Jul; 65(7):493-9. PubMed ID: 20662317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: influence of PEG coating on the particle size, drug release rate and phagocytic uptake.
    Fontana G; Licciardi M; Mansueto S; Schillaci D; Giammona G
    Biomaterials; 2001 Nov; 22(21):2857-65. PubMed ID: 11561891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles.
    Huang M; Wu W; Qian J; Wan DJ; Wei XL; Zhu JH
    Acta Pharmacol Sin; 2005 Dec; 26(12):1512-8. PubMed ID: 16297352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
    Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
    Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of docetaxel and Poloxamer 235 by PLGA-TPGS nanoparticles for breast cancer treatment.
    Tang X; Liang Y; Feng X; Zhang R; Jin X; Sun L
    Mater Sci Eng C Mater Biol Appl; 2015 Apr; 49():348-355. PubMed ID: 25686959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
    Devrim B; Kara A; Vural İ; Bozkır A
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles.
    Steiner V; Öhlinger K; Corzo C; Salar-Behzadi S; Fröhlich E
    Eur J Pharm Sci; 2019 Aug; 136():104968. PubMed ID: 31233864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.
    Ranjan AP; Zeglam K; Mukerjee A; Thamake S; Vishwanatha JK
    Nanotechnology; 2011 Jul; 22(29):295104. PubMed ID: 21693801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles for oral drug delivery: chitosan coating improves stability, controlled delivery, mucoadhesion and cellular uptake.
    Luo Y; Teng Z; Li Y; Wang Q
    Carbohydr Polym; 2015 May; 122():221-9. PubMed ID: 25817662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimization preparation of chansu-loaded solid lipid nanoparticles by central composite design and response surface method].
    Yang Y; Feng JF; Zhang H; Luo JY
    Zhongguo Zhong Yao Za Zhi; 2006 Apr; 31(8):650-3. PubMed ID: 16830822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of 10-hydroxycamptothecin semisolid lipid nanoparticles and investigation of its stability].
    Xi N; Hou LB; Yan XQ; Jiang QF; Wang CX
    Zhong Yao Cai; 2006 Jan; 29(1):63-6. PubMed ID: 16722323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying.
    Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of particle size and MePEG molecular weight on in vitro macrophage uptake and in vivo long circulating of stealth nanoparticles in rats].
    Fang C; Shi B; Hong MH; Pei YY; Chen HZ
    Yao Xue Xue Bao; 2006 Apr; 41(4):305-12. PubMed ID: 16856473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size.
    Fang C; Shi B; Pei YY; Hong MH; Wu J; Chen HZ
    Eur J Pharm Sci; 2006 Jan; 27(1):27-36. PubMed ID: 16150582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
    Girotra P; Singh SK; Kumar G
    Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.